Wikipedia:WikiProject Pharmacology/Assessment

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Welcome to the assessment department of WikiProject Pharmacology! This department focuses on assessing the quality of Wikipedia's articles related to pharmacology and drug-related articles. While much of the work is done in conjunction with the WP:1.0 program, the article ratings are also used within the project itself to aid in recognizing excellent contributions and identifying topics in need of further work.

The ratings are done in a distributed fashion through parameters in the {{WikiProject Pharmacology}} project banner; this causes the articles to be placed in the appropriate sub-categories class and importance.

Frequently asked questions[edit]

How can I get my article rated? 
Please list it in the section for assessment requests below.
Who can assess articles? 
Any member of WikiProject Pharmacology is free to add or change the rating of an article.
Why didn't the reviewer leave any comments? 
Unfortunately, due to the volume of articles that need to be assessed, we are unable to leave detailed comments in most cases. If you have particular questions, you might ask the person who assessed the article; they will usually be happy to provide you with their reasoning. If you're looking for more specific and detailed help in improving an article, you might try peer review, Good Article candidate review, or Pharmacology Collaboration of the Week.
What if I don't agree with a rating? 
You can list it in the section for assessment requests below, and someone will take a look at it. Alternately, you can ask any member of the project to rate the article again.
Aren't the ratings subjective? 
Yes, they are, but it's the best system we've been able to devise; if you have a better idea, please don't hesitate to let us know!

If you have any other questions not listed here, please feel free to ask them on the discussion page for this department.

Article quality[edit]

Quality assessment[edit]

An article's quality assessment is generated from the class parameter in the {{WikiProject Pharmacology}} project banner on its talk page:

{{WikiProject Pharmacology|class=???}}

The following values may be used for the class parameter to describe the quality of the article (see Wikipedia:Quality scale for assessment criteria):

FA (for featured articles only; adds articles to Category:FA-Class pharmacology articles) Featured article FA 
A (adds articles to Category:A-Class pharmacology articles) A-Class article A 
GA (for good articles only; adds articles to Category:GA-Class pharmacology articles)  GA 
B (adds articles to Category:B-Class pharmacology articles) B-Class article B 
C (adds articles to Category:C-Class pharmacology articles) C-Class article C 
Start (adds articles to Category:Start-Class pharmacology articles) Start-Class article Start 
Stub (adds articles to Category:Stub-Class pharmacology articles) Stub-Class article Stub 
FL (for featured lists only; adds articles to Category:FL-Class pharmacology articles) Featured list FL 
List (adds articles to Category:List-Class pharmacology articles)  List 

For pages that are not articles, the following values can also be used for the class parameter:

NA (for any other pages where assessment is unnecessary; adds pages to Category:NA-Class pharmacology articles)  NA 
??? (articles for which a valid class has not yet been provided are listed in Category:Unassessed pharmacology articles)  ??? 

Please note that FA-Class and GA-Class article assessments are not assigned automatically through this system. Instead, an article must be reviewed first at WP:FAC or WP:GAC. A-Class assessments are not currently used by WikiProject Pharmacology.

Quality scale[edit]

WikiProject article quality grading scheme

Topic importance[edit]

Importance assessment[edit]

An article's importance assessment is generated from the importance parameter in the {{WikiProject Pharmacology}} project banner on its talk page:

{{WikiProject Pharmacology| ... | importance=??? | ...}}
Top
High
Mid
Low
???

The following values may be used for importance assessments:

Importance scale[edit]

Label Criteria Examples
Top This is the highest importance. Articles rated as top-importance are generally major classes of drugs, or a major concept of pharmacology. Interestingly enough, there are no actual individual drug articles assessed at this level. Anti-inflammatory, Beta blocker, Clinical trial, Pharmacogenomics
High Articles assessed as high-importance generally include major drugs, like a prototype drug for a class, the first drug discovered in a class, or a drug that has received major media coverage. Penicillin, Caffeine, LSD, Viagra
Mid Drugs which are commonly prescribed and/or used but not the major drug in its class, are assessed at mid-importance. Examples include Daunorubicin (similar to Doxorubicin, which is assessed high, but with over 2,000 known DOX analogs, we're not putting all of them at high-importance ;-). Kanamycin, Tetracaine
Low Drugs assessed at low-importance is pretty much everything else. Not very well known, primarily research compounds that are not on the market but might be used in the laboratory for studies, etc,... PA 824, 5-Methoxytryptamine

Requesting an assessment[edit]

See also: Archive

If you have made significant changes to an article and would like an outside opinion on a new rating for it, please feel free to list it below. Please note that, if you would like an article assessed for FA or GA status, that is must be nominated at WP:FAC or WP:GAC, respectively.

Requested assessments

  • Hi - I'd appreciate it if someone could assess N-methylphenethylamine. Thanks! Seppi333 (talk) 22:52, 14 September 2013 (UTC)
  • PLEASE NEED HELP BUILDING THE GW Pharmaceuticals AND THE Hortapharm B.V. PAGE, THEY ARE THE BIGGEST LEGAL CANNABIS GROWERS IN THE WORLD AND HAVE TEAMED UP WITH BAYER, MONSANTO AND THE DEA.Vjiced (talk) 13:26, 5 August 2012 (UTC)
    • I'm requesting re-assesment of these two articles. Vjiced classified them both as High importance to four different Wikiprojects. I strongly doubt that they're actually high importance to any of them given the amount of editor attention they've received. --Aurochs (Talk | Block) 02:03, 2 November 2012 (UTC)
  • My group created the Discovery and development of thalidomide and its analogs page. We would like assessment and comments about the page. The page was created as a part of our course in Medicinal Chemistry in the University of Iceland. We are 3 pharmaceutical students on our 5th and final year of study, hoping that this page will expand in the coming years. HlynurT (talk) 13:52, 26 September 2012 (UTC)
  • I updated the Nisoxetine page, please let me know what you think. It's primarily a research drug, so not much clinical data. - Julia User:Juliagall
    • Rated C. Will nominate it for DYK and probably do a bit more copyedit over the next few days. Nice work. --ἀνυπόδητος (talk) 18:39, 16 May 2012 (UTC)
  • I would suggest the article Nitrazepam be re-written by someone without such a selective dislike of nitrazepam. It reads like an amateur anti-benzo rant, and its highly selective references to pubmed articles is likely to mislead. I would downrate it to 'C', not 'B', as its overall effect is to terrify people taking this drug, not inform them. --Posted by 120.148.2.96 (talk · contribs).
Cross-posted at WT:PHARM#Nitrazepam. --ἀνυπόδητος (talk) 17:17, 26 February 2012 (UTC)

The article cites the majority of the biased statements to a selection of outdated primary research as well as case reports. Should be pruned to recent review articles and teaching texts according to WP:MEDRS. Remove first everything cited to case reports and primary research, in particular medical claims based on in vitro results with rat cells, cancer cells etc. Virtually everything has once been observed, investigated and contradicted in primary research. Virtually everything has been once reported in a case report of some patient. 70.137.146.59 (talk) 01:17, 8 March 2012 (UTC)